Osteoporosis Mechanism of Disease Animation

Created for Biopharmaceutical client
The project

Created for disease state education on the molecular pathways underlying osteoporosis. Sclerostin is one of many factors that affects the downregulation of osteoblasts and overactivity of osteoclasts. The resulting imbalance can lead to fragility fractures in patients with osteoporosis.

Created for
Biopharmaceutical client

COVID-19 Update:
In alignment with public health directives, we continue to prioritize the safety of our staff and uninterrupted service to our clients.
We are open for business. Wishing you good health and resilience. We’re all in this together.